Bionor Pharma

Bionor Pharma ASA is a biotechnology company dedicated to developing vaccines for viral diseases. It focuses on the development of Vacc-4x, a therapeutic vaccine candidate for human immunodeficiency virus (HIV), which is currently in clinical trials to reduce viral load and kill virus-producing cells. The company is also working on Vacc-C5, a peptide designed to induce antibody responses against the HIV gp120 C5 domain, and Vacc-FLU, a preclinical influenza vaccine. Additionally, it offers nutraceuticals such as Nutri5 and NutriPro. The company was formerly known as Nutri Pharma ASA and changed its name to Bionor Pharma ASA in June 2010.